Enanta Pharmaceuticals, Inc.ENTANASDAQ
Loading
Net Debt Over TimeElevated
Percentile Rank93
Studio
Year-over-Year Change

Total debt minus cash and cash equivalents

Percentile
P93
Near historical high
vs 2Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
2025$168.76M-10.6%
2024$188.82M+37.8%
2023$137.05M+891.8%
2022$-17.31M+65.6%
2021$-50.37M+35.0%
2020$-77.55M-52.0%
2019$-51.03M+19.8%
2018$-63.61M+2.5%
2017$-65.22M-306.4%
2016$-16.05M-